Author:
Niro G.A.,Fontana R.,Gioffreda D.,Fiorella S.,Accadia L.,Iacobellis A.,Caruso N.,Conoscitore P.,Andriulli A.
Subject
Gastroenterology,Hepatology
Reference28 articles.
1. de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, et al. EASL International Consensus Conference on Hepatitis B, 13–14 September, 2002, Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003;39(Suppl. 1):S3–25.
2. A randomized, controlled trial of 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis virus DNA without hepatitis Be antigen in serum;Lampertico;Hepatology,1997
3. Interferon alpha treatment and retreatment of hepatitis Be antigen-negative chronic hepatitis B;Manesis;Gastroenterology,2001
4. Outcome of anti-HBe positive chronic hepatitis in alpha-Interferon treated and untreated patients: a long term cohort study;Brunetto;J Hepatol,2002
5. Efficacy of lamivudine in patients with hepatitis Be antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group;Tassopoulos;Hepatology,1999
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献